SCHEMBL8259233

SCHEMBL8259233

CC(=O)Nc1cccc(Nc2ncnc3[nH]c(-c4cccc(N)c4)cc23)c1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.57
BRAF P15056 7/20 0.54
TNNI3K Q59H18 6/20 0.54
EGFR P00533 4/20 0.52
ALDH1A1 P00352 1/20 0.50
PIP4K2A P48426 1/20 0.49
PIK3CG P48736 1/20 0.49
RAF1 P04049 1/20 0.48
JAK3 P52333 1/20 0.47
MELK Q14680 1/20 0.47
MAP4K4 O95819 1/20 0.47
EIF2AK2 P19525 1/20 0.47
GSK3B P49841 1/20 0.47
KIT P10721 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
MAPT P10636 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7496440 0.88 ABCG2 (0.53) ABCG2BRAFTNNI3KEGFRJAK3
SCHEMBL8259230 0.86 BRAF (0.58) BRAFTNNI3KEGFREIF2AK2GSK3B
SCHEMBL8255837 0.84 CSNK2A2 (0.56) BRAFTNNI3KEGFRALDH1A1KDM4E
SCHEMBL8255818 0.84 EGFR (0.58) BRAFTNNI3KEGFRALDH1A1RAF1
SCHEMBL8256959 0.83 EIF2AK2 (0.62) BRAFTNNI3KEGFRRAF1EIF2AK2
SCHEMBL7494933 0.81 EGFR (0.61) ABCG2BRAFTNNI3KEGFR
SCHEMBL4773624 0.81 EGFR (0.59) BRAFTNNI3KEGFRKDM4EMEN1
SCHEMBL8257149 0.81 EGFR (0.54) BRAFTNNI3KEGFRMAP4K4EIF2AK2
SCHEMBL5559096 0.81 BRAF (0.53) BRAFTNNI3KEGFRRAF1EIF2AK2
SCHEMBL8257175 0.80 EIF2AK2 (0.57) ABCG2BRAFTNNI3KEGFREIF2AK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7253166-B2 6-phenyl-7H-pyrrolo[2,3-d]pyrimidine compounds that induce neuronal differentiation in embryonic stem cells IRM LLC (BM) 2007-08-07 US disclosed
US-20050038049-A1 Compounds that induce neuronal differentiation in embryonic stem cells THE SCRIPPS RESEARCH INSTITUTE (US) 2005-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038049-A1 Compounds that induce neuronal differentiation in embryonic stem cells FER, ERBB3, FLT3 ABCG2 2110/4885BRAF 57/4885TNNI3K 511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.